A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes-Reference-Cited by-同舟云学术

A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes

Published:2019-07-15 Issue:8 Volume:32 Page:1707-1721
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Matlock Matthew K.¹^ORCID,Tambe Abhik¹,Elliott-Higgins Jack¹,Hines Ronald N.²^ORCID,Miller Grover P.³^ORCID,Swamidass S. Joshua⁴^ORCID

Affiliation:

1. Department of Pathology and Immunology, Washington University in St. Louis, Saint Louis, Missouri 63110, United States

2. National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States

3. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States

4. Institute for Informatics, Washington University in St. Louis, Saint Louis, Missouri 63110, United States

Funder

U.S. Department of Health and Human Services

Department of Immunology and Pathology, Washington University School of Medicine

Center for Biological Systems Engineering, Washington University

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.9b00223

Reference73 articles.

1. Assessing the Economic Impact of Adverse Drug Effects

2. Counting the Costs of Drug-Related Adverse Events

3. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

4. Idiosyncratic drug reactions: the reactive metabolite syndromes

5. Managing the challenge of chemically reactive metabolites in drug development

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of in vitro models for pediatric translational research;Essentials of Translational Pediatric Drug Development;2024

2. Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities;Pharmaceutics;2023-11-03

3. Intracellular spatiotemporal metabolism in connection to target engagement;Advanced Drug Delivery Reviews;2023-09

4. Advances in computational methods along the exposure to toxicological response paradigm;Toxicology and Applied Pharmacology;2022-09

5. Use of Biomarker Data and Relative Potencies of Mutagenic Metabolites to Support Derivation of Cancer Unit Risk Values for 1,3-Butadiene from Rodent Tumor Data;Toxics;2022-07-15